Skip to main content
. Author manuscript; available in PMC: 2020 Aug 18.
Published in final edited form as: Cancer Chemother Pharmacol. 2016 Oct 13;78(5):1051–1058. doi: 10.1007/s00280-016-3166-8

Fig. 1.

Fig. 1

Plasma Dnr and DOL PK. Plasma concentration/time curve for (a) Dnr and (b) DOL in AML patients receiving a 60 mg/m2 dose of Dnr. The black curve is the median, the blue shaded region is the 25th–75th percentile, and the gray shaded region is the 5th–95th percentile of the population pharmacokinetics